Interviewing Peter Lio, Clinical Assistant Professor of Dermatology and Pediatrics, Northwestern University Feinberg School of Medicine

Since December 2019, the new severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) from Wuhan, China, has been the aetiological agent of COVID-19 disease, an infectious disease that has evolved into a global pandemic.1 Androgenetic alopecia (AGA), the most common type of alopecia,2 is an androgen-dependent condition, the main androgen responsible for the follicular pathology being dihydrotestosterone.3

THE EUROPEAN Academy of Dermatology and Venereology (EADV) 2021 Virtual Congress successfully brought together influential clinicians and academics from across the globe, working to achieve the EADV’s aims of “improving the quality of patient care, furthering knowledge and education of dermatologists and venereologists globally through innovation, and advocating on behalf of the speciality and patients.” Rather than viewing the online conference as an obligation, born out of necessity during the COVID-19 pandemic, the EADV instead transformed it into an opportunity. This was underscored by Alexander Stratigos, President of the EADV, during the welcome address: “As we move toward a post-pandemic era, our Academy is emerging ever stronger, with a vibrant day-to-day education programme that exploits the unique opportunities presented by digital learning.” Stratigos added: “Through our evolving digital learning ecosystem, we are able to deliver a multitude of online experiences, including webinars, enhanced digital communications, e-learning, and web-based tools to support continuous medical education and allow a broader diffusion of knowledge.”

The latest international guidelines on urticaria were published in September as a joint initiative from the European Academy of…

THE ANNIVERSARY edition of the European Academy of Dermatology and Venereology’s (EADV) 30th Congress was held between 29th September and 2nd October 2021. As COVID-19 remains a barrier to global travel, the EADV’s 30th Anniversary Congress was staged virtually, providing access to the latest research, breakthroughs, and scientific advances to dermato-venereology professionals.

Recent years have witnessed significant advances in the understanding of facial anatomy. Extensive studies have uncovered the arrangement of soft-tissue layers underlying the skin and their mobility during expression. Meanwhile, increasing awareness of the facial vascular network has laid the foundation for lower risk cosmetic procedures.

One year after the identification of the novel severe acute respiratory syndrome 2 (SARS-CoV-2) infection in Wuhan, China, and the outbreak of the virus worldwide, the pandemic state persists, and the management of COVID-19 remains burdensome, with the number of people infected daily increasing progressively in most countries and the death rate being alarmingly elevated.1

An interview with Roxana Daneshjou, Clinical Scholar of Dermatology, Stanford University, California, USA.

Melanoma is a prominent type of skin cancer and treatment varies depending on the mutation and malignancy of the disease. The overall survival (OS) rate of metastatic melanoma is 35–50%. Pablo Fernandez-Peñas, Westmead Hospital, Sydney Medical School, Australia, opened the session by stating the discussion was based on BRAF-mutated melanoma. Fernandez-Peñas attested that targeted therapies are not beneficial for BRAF wild-type melanoma.